Literature DB >> 7153335

Chronic granulomatous disease: fatal septicemia caused by an unnamed gram-negative bacterium.

R A Seger, D G Hollis, R E Weaver, W H Hitzig.   

Abstract

A 2-year-old boy with proven X-linked chronic granulomatous disease was placed under continuous co-trimoxazole prophylaxis. He remained free of infection for 4 years. At age 6.25 years, he suddenly developed a fever with no localizing signs and died 16 days later in septic shock. A gram-negative, catalase-positive, halophilic, aerobic bacterium was cultured from blood, bone marrow, and ascitic fluid. This organism could not be identified in microbiological laboratories in Europe and the United States. Its biochemical features indicate that it may belong to a species which has not previously been described.

Entities:  

Mesh:

Year:  1982        PMID: 7153335      PMCID: PMC272483          DOI: 10.1128/jcm.16.5.821-825.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Agents responsible for infection in chronic granulomatous disease of childhood.

Authors:  G M Lazarus; H C Neu
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

2.  Pseudomonas putrefaciens isolates from clinical specimens.

Authors:  P S Riley; H W Tatum; R E Weaver
Journal:  Appl Microbiol       Date:  1972-11

3.  Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function.

Authors:  B Holmes; P G Quie; D B Windhorst; R A Good
Journal:  Lancet       Date:  1966-06-04       Impact factor: 79.321

4.  Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood.

Authors:  S J Klebanoff; L R White
Journal:  N Engl J Med       Date:  1969-02-27       Impact factor: 91.245

5.  Chronic granulomatous disease: correlation between pathogenesis and clinical findings.

Authors:  R B Johnston; R L Baehner
Journal:  Pediatrics       Date:  1971-11       Impact factor: 7.124

6.  Simplified silver-plating stain for flagella.

Authors:  M West; N M Burdash; F Freimuth
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

7.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

8.  Protection of phagocytized bacteria from the killing action of antibiotics.

Authors:  B Holmes; P G Quie; D B Windhorst; B Pollara; R A Good
Journal:  Nature       Date:  1966-06-11       Impact factor: 49.962

9.  Leukocyte bactericidal activity in chronic granulomatous disease: correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing.

Authors:  G L Mandell; E W Hook
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

10.  Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP).

Authors:  Y Kobayashi; D Amano; K Ueda; Y Kagosaki; T Usui
Journal:  Eur J Pediatr       Date:  1978-04-20       Impact factor: 3.183

View more
  4 in total

1.  Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease.

Authors:  D G Hollis; R E Weaver; A G Steigerwalt; J D Wenger; C W Moss; D J Brenner
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

2.  Problems in identification of Francisella philomiragia associated with fatal bacteremia in a patient with chronic granulomatous disease.

Authors:  A Friis-Møller; L E Lemming; N H Valerius; B Bruun
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Francisella philomiragia adenitis and pulmonary nodules in a child with chronic granulomatous disease.

Authors:  Timothy L Mailman; Matthias H Schmidt
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

Review 4.  Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?

Authors:  Devyn D Gillette; Susheela Tridandapani; Jonathan P Butchar
Journal:  Front Cell Infect Microbiol       Date:  2014-02-21       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.